TORII PHARMACEUTICAL CO.,LTD. 4551Short Interest
Estimated short interest in TORII PHARMACEUTICAL CO.,LTD. (4551) is 0.95% of shares outstanding as of 2022-12-15. No institution currently holds 0.5% or more.
Estimated short interest
0.9500%
▼0.0200%
Estimated position (shares)
276,879
As of 2022-12-15
Short sellers
2 firms
15 reports
Short Interest Trend By institution, % of shares outstanding
Estimated short interest, stacking the latest reported position of each short seller. The 2 largest current holders are shown in color and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- MERRILL LYNCH INTERNATIONAL
- Integrated Core Strategies (Asia) Pte. Ltd.
0.9500%
Estimated short interest, 2022-12-15
Integrated Core Strategies (Asia) Pte. Ltd.0.46%
MERRILL LYNCH INTERNATIONAL0.49%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2022-12-15 | MERRILL LYNCH INTERNATIONAL | Position 142,279 shares | Ratio 0.4900% | ▼0.0201% | Below 0.5% |
| 2019-03-12 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 134,600 shares | Ratio 0.4600% | ▼0.1300% | Below 0.5% |
Disclosure History 15 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2022-12-15 | MERRILL LYNCH INTERNATIONAL | Position 142,279 shares | Ratio 0.4900% | ▼0.0201% | Below 0.5% |
| 2022-12-14 | MERRILL LYNCH INTERNATIONAL | Position 147,279 shares | Ratio 0.5100% | ▲0.0100% | — |
| 2022-12-06 | MERRILL LYNCH INTERNATIONAL | Position 144,479 shares | Ratio 0.5000% | ▲0.0100% | — |
| 2022-11-18 | MERRILL LYNCH INTERNATIONAL | Position 143,979 shares | Ratio 0.4900% | ▼0.0101% | Below 0.5% |
| 2022-11-17 | MERRILL LYNCH INTERNATIONAL | Position 146,879 shares | Ratio 0.5000% | ▼0.0101% | — |
| 2022-11-10 | MERRILL LYNCH INTERNATIONAL | Position 147,874 shares | Ratio 0.5100% | ▲0.0100% | — |
| 2022-11-04 | MERRILL LYNCH INTERNATIONAL | Position 145,774 shares | Ratio 0.5000% | ▼0.0101% | — |
| 2022-11-01 | MERRILL LYNCH INTERNATIONAL | Position 148,674 shares | Ratio 0.5100% | ▲0.0100% | — |
| 2022-10-31 | MERRILL LYNCH INTERNATIONAL | Position 146,074 shares | Ratio 0.5000% | ▲0.0200% | — |
| 2019-03-12 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 134,600 shares | Ratio 0.4600% | ▼0.1300% | Below 0.5% |
| 2019-02-05 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 171,000 shares | Ratio 0.5900% | ▼0.0101% | — |
| 2019-01-25 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 172,800 shares | Ratio 0.6000% | ▲0.0200% | — |
| 2018-12-13 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 169,800 shares | Ratio 0.5800% | ▼0.0201% | — |
| 2018-11-26 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 174,079 shares | Ratio 0.6000% | ▲0.0999% | — |
| 2018-11-01 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 145,000 shares | Ratio 0.5000% | ▲0.0999% | — |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| GNI Group Ltd.2160 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kyowa Kirin Co.,Ltd.4151 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Takeda Pharmaceutical Company Limited4502 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Core30 |
| Astellas Pharma Inc.4503 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| Sumitomo Pharma Co.,Ltd.4506 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |